|
⚲
|
| Keyboard |
| RTW Innovation Master Fund Ltd
✚
|
|
|---|---|
| CIK # | 0001776733 |
| CIK | Period |
|---|---|
| 0001776733 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Immunocore Holdings PLC | 0.4 | ||
| Inotek Pharmaceuticals Corp | 0.4 | ||
| Alnylam Pharmaceuticals Inc | 0.3 | ||
| Axsome Therapeutics Inc | 0.3 | ||
| PTC Therapeutics Inc | 0.3 | ||
| Ultragenyx Pharmaceutical Inc | 0.2 | ||
| Acadia Pharmaceuticals Inc | 0.2 | ||
| Penumbra Inc | 0.2 | ||
| Bruker Corp | 0.2 | ||
| Argenx SE | 0.2 | ||
| Establishment Labs Holdings Inc | 0.2 | ||
| Thermo Fisher Scientific Inc | 0.2 | ||
| Protagonist Therapeutics Inc | 0.1 | ||
| Natera Inc | 0.1 | ||
| Aastrom Biosciences Inc | 0.1 | ||
| Celldex Therapeutics Inc | 0.1 | ||
| Cytokinetics Inc | 0.1 | ||
| 10X Genomics Inc | 0.1 | ||
| Illumina Inc | 0.1 | ||
| Intuitive Surgical Inc | 0.1 | ||
| Synta Pharmaceuticals Corp | 0.1 | ||
| Stoke Therapeutics Inc | 0.0 | ||
| Tarsus Pharmaceuticals Inc | 0.0 | ||
| Health Sciences Acquisitions Corp 2 | 0.0 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001776733] | |
| 3 | [0001776733] | |
| 4 | [0001776733] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Allurion Technologies Inc | |
| RTW Innovation Master Fund Ltd | |
| Wong Roderick | |
| RTW Master Fund Ltd | |
| RTW Investments LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 96,896 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 767,848 | $1.67 | 1,282,306 |
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 991,544 | ||
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 767,848 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 991,544 | $1.67 | 1,655,878 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 96,896 | $1.67 | 161,816 |
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $2,756,117.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $2,756,117.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $126,839.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $2,117,044.00 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 822,722 | $3.35 | 2,756,119 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 631,954 | $3.35 | 2,117,046 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 37,863 | $3.35 | 126,841 |
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $126,839.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $2,117,044.00 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 822,722 | $3.35 | 2,756,119 |
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-04-16 | Conversion | $5,000,000.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-04-16 | Grant | $5,000,000.00 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 631,954 | $3.35 | 2,117,046 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 37,863 | $3.35 | 126,841 |